Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Erythropoietin (EPO) attenuates the expression of its receptor (EPO-R) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats

Drosos Tsavlis, Anna Tzoumaka, Georgia Kokaraki, Kokkona Kouzi-Koliakou, Anastasia Tektonidou, Afroditi Papadopoulou, Evangelia Spandou
European Respiratory Journal 2012 40: P3753; DOI:
Drosos Tsavlis
1Department of Experimental Physiology, School of Medicine, Aristotle University, Thessaloniki, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Tzoumaka
1Department of Experimental Physiology, School of Medicine, Aristotle University, Thessaloniki, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgia Kokaraki
1Department of Experimental Physiology, School of Medicine, Aristotle University, Thessaloniki, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kokkona Kouzi-Koliakou
1Department of Experimental Physiology, School of Medicine, Aristotle University, Thessaloniki, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anastasia Tektonidou
1Department of Experimental Physiology, School of Medicine, Aristotle University, Thessaloniki, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Afroditi Papadopoulou
1Department of Experimental Physiology, School of Medicine, Aristotle University, Thessaloniki, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evangelia Spandou
1Department of Experimental Physiology, School of Medicine, Aristotle University, Thessaloniki, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

PURPOSE:PF is characterized by apoptosis as well as by inflammation, excessive collagen deposition and fibroplasts' proliferation.The EPO-R is well known to play an important role in the fibrotic-apoptotic pathway. EPO is a multiple functional cytokine with anti-apoptotic, anti-oxidative and anti-inflammatory properties.We looked for the effect of EPO on BLM-induced lung fibrosis, by examining the expression of EPO-R in the lung tissue of rats.

MATERIAL AND METHODS: Fifty Wistar rats (300gr) were divided into five groups of 10 animals each:1)control animals,2)intratracheal (i.t) and intraperitoneal (i.p) injection of saline (0.5ml/kg),3)BLM hydrochloride (7.5mg/kg) i.t injection,4)BLM hydrochloride (7.5mg/kg) i.t injection followed by EPO i.p injection (2000 iu/kg),5)saline (0.5ml/kg) i.t injection followed by EPO i.p injection (2000 iu/kg). All rats were sacrified after 14 days.Immunohistochemical evaluation was performed for the expression of EPO-R.A scale of 4 grades was used for the evaluation of the results: 0-25% (A),25-50% (B),50-75% (C),75-100% (D).

RESULTS: In groups 1,2 and 5 (control groups), EPO-R was expressed in the lower grades A (80%) and B (20%). In group 3 (BLM group), EPO-R was expressed in the high grades B (20%), C (70%) and D (10%). In group 4 (EPO group), EPO-R was expressed only in the low grades A (50%) and B (50%). The expression of EPO-R took place in the high grades for BLM group and in the lower grades for BLM+EPO group (p<0.05).

CONCLUSION: BLM injection followed by EPO resulted in significant lower expression of EPO-R compared with BLM group. The protective mechanisms of EPO on PF must be further clarified.

  • Animal models
  • Experimental approaches
  • Interstitial lung disease
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Erythropoietin (EPO) attenuates the expression of its receptor (EPO-R) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Erythropoietin (EPO) attenuates the expression of its receptor (EPO-R) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
Drosos Tsavlis, Anna Tzoumaka, Georgia Kokaraki, Kokkona Kouzi-Koliakou, Anastasia Tektonidou, Afroditi Papadopoulou, Evangelia Spandou
European Respiratory Journal Sep 2012, 40 (Suppl 56) P3753;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Erythropoietin (EPO) attenuates the expression of its receptor (EPO-R) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
Drosos Tsavlis, Anna Tzoumaka, Georgia Kokaraki, Kokkona Kouzi-Koliakou, Anastasia Tektonidou, Afroditi Papadopoulou, Evangelia Spandou
European Respiratory Journal Sep 2012, 40 (Suppl 56) P3753;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • LSC Abstract – microRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease
  • Therapeutic efficacy of a novel LPA1 receptor antagonist, UD-009, in a bleomycin-induced pulmonary fibrosis model
  • Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD
Show more 3.3 Mechanisms of Lung Injury and Repair

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society